Navigation Links
Cytokinetics announces fundamental research in cardiac myosin activation in the journal Science
Date:3/17/2011

pleted in patients with heart failure. In addition, five Phase I clinical trials of omecamtiv mecarbil were conducted in healthy subjects. Data from each of these trials have been reported previously.

Amgen holds an exclusive, world-wide (excluding Japan) license to omecamtiv mecarbil and related compounds, subject to specified development and commercialization participation rights of Cytokinetics. In February 2011, the company and its partner, Amgen Inc., announced plans to initiate a Phase IIb clinical trial of an intravenous formulation of omecamtiv mecarbil to evaluate its safety and efficacy in patients with left ventricular systolic dysfunction hospitalized for acute heart failure in the first half of 2011.


'/>"/>

Contact: Christopher Keenan
ckeenan@cytokinetics.com
415-505-2581
Cytokinetics, Inc.
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology technology :

1. Amgen Exercises Option for Exclusive License to Cytokinetics Cardiac Contractility Program That Includes CK-1827452
2. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter 2009 Financial Results
3. Odyssey Thera Announces Milestone Achievement in Pfizer Alliance
4. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
5. Anesiva Announces Second Quarter 2008 Financial Results and Update
6. SGX Pharmaceuticals Announces Financial Results for the Three and Six Months Ended June 30, 2008
7. Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008
8. China Sky One Medical, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
9. China Yingxia International, Inc. Announces Conference Call to Discuss Second Quarter 2008 Results
10. ThirdBiotech Announces Kemeta as Newest Sponsor
11. Signalife Announces Intent to Withdraw From AMEX and Trade on the OTCBB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... German . Photographers ... you can see which branch a bird is sitting on, ... the telephoto lens for high-magnification images requires considerable skill. It ... study proteins, the active biomolecules of cells. , Olga Schubert, ... Biology, and her colleagues have now come up with a ...
(Date:5/17/2013)... USA (PRWEB) May 17, 2013 •    First ... Globes Certified for sustainability ,     New facility will ... , Syngenta unveiled its new ... at the company’s RTP Innovation Center. The first of ... researchers to simulate any agricultural climate and precisely measure ...
(Date:5/17/2013)... -- Yongye International, Inc. (NASDAQ: YONG ) ("Yongye" ... of crop nutrient products in the People,s ... May 16, 2013, the special committee (the "Special Committee") ... was provided a letter (the "Letter") issued by Abax ... ("Abax") to Full Alliance International Limited ("Full Alliance"). The ...
(Date:5/17/2013)... 17, 2013 Men’s skin is biologically different ... Posay ) and has been known to react more aggressively ... may be far from puberty, other acne causing factors like ... breakouts, and threatening skin with unsightly acne scars. Adult acne ... Men’s Health on how to reduce and prevent acne ...
Breaking Biology Technology:Proteome atlas for the tuberculosis pathogen 2Proteome atlas for the tuberculosis pathogen 3Syngenta Opens Unique $72 Million Advanced Crop Lab 2Syngenta Opens Unique $72 Million Advanced Crop Lab 3Yongye International Provides Update on Status of Proposed Go Private Offer 2Yongye International Provides Update on Status of Proposed Go Private Offer 3Yongye International Provides Update on Status of Proposed Go Private Offer 4Adult Acne Treatment, Probiotic Action Shares New Insight on Why Men’s Skin Scars from Acne and How to Prevent It 2
... for Pharmaceutical ... ... Codexis, Inc., a private,biotechnology company and leading developer of clean ... California Institute of Technology for preparing and identifying,drug metabolites (substances ...
... Colo., Aug. 29 AspenBio Pharma,Inc. (Nasdaq: APPY ... novel drugs and diagnostics for animals and humans,reported today ... annual Roth,Capital Partners New York Investor Conference to be ... investors are expected to attend the,conference, which will be ...
... of cardiovascular genetics ... ... GeneNews Limited (TSX: GEN),a company focused on developing patient-friendly blood-based ... or medical,condition, today announced that its co-founder and Chief Scientist ...
Cached Biology Technology:Codexis Licenses New Drug Metabolite Profiling and Lead Diversification Technology From the California Institute of Technology 2AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference 2AspenBio Pharma to Present at the Roth Capital Partners New York Investor Conference 3GeneNews' Chief Scientist Dr. C.C. Liew co-editor of new genomics reference book 2
(Date:5/17/2013)... AGA Research Foundation announced a new grant that intends ... microbiota, one of today,s most exciting areas of science, ... Research Awards Panel selected Andrew T. Chan, MD, MPH ... Medical School, Boston, as the 2013 AGA-Elsevier Gut Microbiome ... of funding, commencing in July 2013, to test the ...
(Date:5/17/2013)... investigating the interaction of a group of proteins in ... have identified a new target that could increase cell ... University,s School of Biochemistry and published in the ... could eventually lead to new therapies for stroke and ... work by the team which identified a protein, known ...
(Date:5/17/2013)... Societies for Experimental Biology (FASEB) released a new ... trends highlighting the devastating impact of sequestration on the ... follows a May 15th Senate Appropriations Committee hearing featuring ... the $1.6 billion cut the agency sustained in FY ... on the scientific community." , According to data ...
Breaking Biology News(10 mins):New gut microbiome research to explore red meat -- colorectal cancer pathway 2SUMO wrestling cells reveal new protective mechanism target for stroke 2
... - Wheat plants found to be resistant to Hessian ... up rigid defenses. Christie Williams, a research scientist ... and a Purdue University associate professor of entomology, found ... increased production of surface waxes and cutin, a molecule ...
... GALVESTON, Texas Why do people become physically weaker ... stop, or even reverse this process, breaking the link between ... online this Wednesday in the Journal of Clinical Endocrinology ... researchers present evidence that answers to both those questions can ...
... MN Bringing the power of synchrotron light to ... aim of a Memorandum of Agreement (MOA) signed today ... national synchrotron facility, the Canadian Light Source (CLS). ... scientific and product outcomes while improving operating efficiency for ...
Cached Biology News:Resistant wheat rebuilds cell walls when attacked by Hessian flies 2Muscle loss in elderly linked to blood vessels' failure to dilate 2BioBusiness Alliance, Canadian Light Source Synchrotron sign agreement 2
Invitrogen's Calcium Phosphate Transfection Kit provides high-quality reagents to enable the introduction of DNA into tissue culture cells via calcium phosphate co-precipitation....
Request Info...
...
...
Biology Products: